Innoviva, Inc. 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-03 5:19 pm Purchase |
2021-05-03 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Innoviva Inc. INVA |
44,807,844 70.600% |
7,462,050 (+19.98%) |
Filing |
| 2020-09-01 5:28 pm Purchase |
2020-09-01 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Innoviva Inc. INVA |
37,345,794 69.000% |
34,700,774 (+1311.93%) |
Filing |